Resources |
The Michael S. Bereman Award for Innovative Clinical Proteomics recognizes recent innovations in clinical proteomics from early- and mid-career scientists. The awardee is honored at the annual meeting of MSACL, where they will be invited to give a lecture. Nominees will be reviewed annually by a rolling award committee.
Michael fought daily to make proteomics an answer to questions about disease. His creative efforts have helped guide our approaches and his tenacious spirit will grace this field indefinitely.
From Chris Herold, MSACL President:
Michael Bereman passed on March 17, 2021. Following a diagnosis of ALS in 2015 he was
racing against time for the next 6 years to understand the cause of sporadic ALS and
identify diagnostic and prognostic markers; more time than is generally
expected - likely due to an unbridled positive attitude and deep support network of
family, friends and colleagues.
I first met Michael at MSACL 2015 US where he was a co-instructor for the Quantitative
Proteomics course with Mike MacCoss. I remember him vividly, joking with us at
the MSACL registration desk; so personable, so friendly, so genuine. That was just before
his diagnosis.
He returned for MSACL 2016 and 2017 in Palm Springs to reprise his co-instructor role in
the Quantitative Proteomics course, but with a heavier burden, and not one I
was aware
of until later. But, you know what? Michael was still at the registration desk making us
laugh. His smiling face remains in my memories and thoughts, now forever.
He embodied what I hope and envision I will also: courage, fortitude, direction,
positivity, love, passion and philanthropy. To the very, very end he was fighting for
his
family, and to alleviate the pain for others who may end up in a similar situation. While
his has been a trying path, it has also been beautiful in its sincerity. He
touched
many profoundly. He made the world a better place. Thanks Michael. We will miss you. And
there is no way I can end this with a sad face as I will always remember yours
as
happy. :)
See a video on Michael's story.